SCHEMBL8092294

SCHEMBL8092294

CC(C)NC(=O)Nc1ccc(-c2nc(N)cc(C3(S(=O)(=O)c4ccccn4)CC3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
ATR Q13535 1/20 0.37
GHSR Q92847 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP3A5 P20815 1/20 0.36
EIF2S1 P05198 1/20 0.35
EIF2AK3 Q9NZJ5 1/20 0.35
LIMK1 P53667 2/20 0.35
PIK3CA P42336 2/20 0.35
NAMPT P43490 1/20 0.35
PIK3CD O00329 2/20 0.34
NPC1 O15118 1/20 0.33
BCL2 P10415 1/20 0.33
BECN1 Q14457 1/20 0.33
IGF1R P08069 1/20 0.33
MTOR P42345 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8096070 0.90 MTOR (0.40) ATRPIK3CANAMPTPIK3CDIGF1R
SCHEMBL8098769 0.89 NAMPT (0.39) ROCK2CA12CA1CA2CA9
SCHEMBL8098135 0.89 MTOR (0.39) ATRPIK3CANAMPTPIK3CDIGF1R
SCHEMBL8092270 0.88 NPC1 (0.43) ATRLIMK1PIK3CANPC1MTOR
SCHEMBL8106295 0.88 CA12 (0.42) ROCK2CA12CA1CA2CA9
SCHEMBL8096681 0.87 ATR (0.40) ATRPIK3CANAMPTIGF1RMTOR
SCHEMBL8091129 0.86 KDR (0.40) CA12CA1CA2CA9ATR
SCHEMBL8091924 0.86 NAMPT (0.39) CA12CA1CA2CA9ATR
SCHEMBL8097714 0.86 NAMPT (0.39) CA12CA1CA2CA9ATR
SCHEMBL8098805 0.85 PIK3CD (0.36) ATRPIK3CANAMPTPIK3CDIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed